Ledger.Open graph →
SEC Form D · filed February 4, 2021

KEMPHARM, INC

Offering
$44.0M
Sold
$44.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CELEBRATION, FL
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Richard W. Pascoe · Celebration, FLDirectorTravis C. Mickle · Celebration, FLExec · Director · PromoterR. L. Clifton · Celebration, FLExecMatthew R. Plooster · Celebration, FLDirectorSven L. Guenther · Celebration, FLExecDavid S. Tierney · Celebration, FLDirectorTimothy J. Sangiovanni · Celebration, FLExecJoseph B. Saluri · Celebration, FLDirectorTodd Hixon · Reston, VAExecKatherine Lewis · Las Vegas, NVDirectorScott Johnson · Reston, VAExec · Director · PromoterCormac Sheehan · New York, NYDirectorStephen Sarsfield · Las Vegas, NVExecKenneth D. Cron · New York, NYExecSims Lansing · New York, NYDirectorStuart N. Ballard · London, United KingdomDirectorAngela P. Ciampa · BOSTON, MADirectorScott B. Garfield · BOSTON, MADirectorVipon B. Ghai · BOSTON, MAExecScott B. Mcfetridge · BOSTON, MAExecBrian R. Albert · BOSTON, MAExec · Director · PromoterPaul A. Fishbin · BOSTON, MADirectorJoshua A. Liebow · BOSTON, MADirectorAdrienne Lerner · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗